Pituitary adenylate cyclase-activating polypeptide (PACAP-38) stimulates rat peritoneal macrophage functions

被引:31
作者
Delgado, M
Garrido, E
DelaFuente, M
Gomariz, RP
机构
[1] UNIV COMPLUTENSE MADRID,FAC BIOL,DEPT BIOL CELULAR,E-28040 MADRID,SPAIN
[2] UNIV COMPLUTENSE MADRID,FAC BIOL,DEPT FISIOL,E-28040 MADRID,SPAIN
关键词
macrophage; pituitary adenylate cyclase-activating polypeptide; phagocytosis; superoxide anion production;
D O I
10.1016/S0196-9781(96)00171-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The present study shows that PACAP-38, in a dose-dependent manner, increased in vitro two steps of the phagocytic process in rat peritoneal macrophages: ingestion of inert particles (latex beads) and production of superoxide anion as measured by nitroblue tetrazolium reduction. The most effective concentration of PACAP-38 was 10(-10) M. Similarly, PMA, an activator of protein kinase C (PKC), increased the phagocytic activity in a dose-dependent manner, whereas retinal, a PKC inhibitor, decreased the activity. Macrophages incubated with forskolin, an enhancer of intracellular cAMP levels, produced an inhibitory effect on both phagocytic functions. The maximum stimulation of the phagocytic activity by PACAP-38 was not further enhanced by addition of PMA, suggesting that the enhancement of the phagocytic activity by PACAP-38 and PMA is mediated by a common signaling pathway. In addition, retinal as well as forskolin inhibited partially the stimulatory effect that PACAP-38 produced in the macrophage functions studied. Furthermore, this study showed that a VIP receptor antagonist was unable to suppress the stimulatory effect of PACAP-38. These results could prove that PACAP-38 stimulates the phagocytosis and production of superoxide anion in macrophages through PKC activation by binding to type I PACAP receptor. Copyright (C) 1996 Elsevier Science Inc.
引用
收藏
页码:1097 / 1105
页数:9
相关论文
共 58 条
[11]  
CHAKDER S, 1993, J PHARMACOL EXP THER, V266, P392
[12]  
CHALTRER N, 1991, ENDOCRINOLOGY, V129, P3367
[13]   INTERACTION OF VIP, PACAP AND RELATED PEPTIDES IN NORMAL AND LEUKEMIC HUMAN MONOCYTES AND MACROPHAGES [J].
CHEDEVILLE, A ;
MIROSSAY, L ;
CHASTRE, E ;
HURBAINKOSMATH, I ;
LOPEZ, M ;
GESPACH, C .
FEBS LETTERS, 1993, 319 (1-2) :171-176
[14]   TYPE-I RECEPTORS FOR PACAP (A NEUROPEPTIDE EVEN MORE IMPORTANT THAN VIP) [J].
CHRISTOPHE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1154 (02) :183-199
[15]   STIMULATION OF PHAGOCYTIC FUNCTION IN MOUSE MACROPHAGES BY NEUROTENSIN AND NEUROMEDIN-N [J].
DELAFUENTE, M ;
GARRIDO, JJ ;
ARAHUETES, RM ;
HERNANZ, A .
JOURNAL OF NEUROIMMUNOLOGY, 1993, 42 (01) :97-104
[16]  
DELAFUENTE M, 1991, IMMUNOLOGY, V73, P205
[17]   CHANGES IN THE MACROPHAGE FUNCTION WITH AGING [J].
DELAFUENTE, M .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR & INTEGRATIVE PHYSIOLOGY, 1985, 81 (04) :935-938
[18]  
DELAFUENTE M, 1993, IMMUNOLOGY, V80, P259
[19]   INHIBITION OF MURINE PERITONEAL MACROPHAGE FUNCTIONS BY SULFATED CHOLECYSTOKININ-OCTAPEPTIDE [J].
DELAFUENTE, M ;
CAMPOS, M ;
DELRIO, M ;
HERNANZ, A .
REGULATORY PEPTIDES, 1995, 55 (01) :47-56
[20]  
DELAFUENTE M, 1993, REGUL PEPTIDES, V48, P347